Literature DB >> 24229845

Increased incidence of serotype-1 invasive pneumococcal disease in young female adults in The Netherlands.

S P Van Mens1, A M M Van Deursen2, S C A Meijvis1, B J M Vlaminckx1, E A M Sanders2, H E De Melker3, L M Schouls3, A Van Der Ende4, S C De Greeff3, G T Rijkers1.   

Abstract

Analysis of the Dutch national invasive pneumococcal disease (IPD) surveillance data by sex reveals an increase in the incidence of serotype-1 disease in young female adults in The Netherlands after the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the national immunization schedule. This has led to an overall increase in IPD in women aged 20-45 years, which was not observed in men of the same age. No other differences in serotype shifts possibly induced by the introduction of PCV7 were observed between the sexes in this age group. Serotype 1 is a naturally fluctuating serotype in Europe and it has been associated with disease in young healthy adults before. It remains uncertain whether or not there is an association between the observed increase in serotype-1 disease in young female adults and the implementation of PCV7 in The Netherlands.

Entities:  

Mesh:

Year:  2013        PMID: 24229845      PMCID: PMC9151292          DOI: 10.1017/S0950268813002860

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  18 in total

1.  Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.

Authors:  Angela B Brueggemann; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes.

Authors:  Sarah Cobey; Marc Lipsitch
Journal:  Science       Date:  2012-03-01       Impact factor: 47.728

3.  Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era.

Authors:  Joshua P Metlay; Ebbing Lautenbach; Yimei Li; Justine Shults; Paul H Edelstein
Journal:  Arch Intern Med       Date:  2010-04-26

4.  Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002-2009.

Authors:  J W T Elston; A Santaniello-Newton; J A Meigh; D Harmer; V Allgar; T Allison; G Richardson; R Meigh; S R Palmer; G Barlow
Journal:  Epidemiol Infect       Date:  2011-11-01       Impact factor: 2.451

Review 5.  Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis.

Authors:  Daniel M Weinberger; Zitta B Harboe; Elisabeth A M Sanders; Moses Ndiritu; Keith P Klugman; Simon Rückinger; Ron Dagan; Richard Adegbola; Felicity Cutts; Hope L Johnson; Katherine L O'Brien; J Anthony Scott; Marc Lipsitch
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

6.  Association of infant pneumococcal vaccination with pneumococcal pneumonia among mothers: a nested case-control study using the GPRD.

Authors:  Eelko Hak; Kimberly M Shea; Susan S Jick
Journal:  Vaccine       Date:  2013-01-25       Impact factor: 3.641

7.  Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.

Authors:  Elske J M van Gils; Reinier H Veenhoven; Eelko Hak; Gerwin D Rodenburg; Debby Bogaert; Ed P F Ijzerman; Jacob P Bruin; Loek van Alphen; Elisabeth A M Sanders
Journal:  JAMA       Date:  2009-07-08       Impact factor: 56.272

8.  Trends in serotype prevalence in invasive pneumococcal disease before and after infant pneumococcal vaccination in Belgium, 2002-2010.

Authors:  Laurens Liesenborghs; Jan Verhaegen; Willy E Peetermans; Jozef Vandeven; Johan Flamaing
Journal:  Vaccine       Date:  2012-12-20       Impact factor: 3.641

9.  Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome.

Authors:  Angelique G S C Jansen; Gerwin D Rodenburg; Arie van der Ende; Loek van Alphen; Reinier H Veenhoven; Lodewijk Spanjaard; Elisabeth A M Sanders; Eelko Hak
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

10.  Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.

Authors:  Stefan Flasche; Albert Jan Van Hoek; Elizabeth Sheasby; Pauline Waight; Nick Andrews; Carmen Sheppard; Robert George; Elizabeth Miller
Journal:  PLoS Med       Date:  2011-04-05       Impact factor: 11.069

View more
  2 in total

1.  Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world.

Authors:  Yadong A Cui; Harshila Patel; William M O'Neil; Se Li; Patricia Saddier
Journal:  Hum Vaccin Immunother       Date:  2017-01-26       Impact factor: 3.452

2.  Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015.

Authors:  Gertjan H J Wagenvoort; Elisabeth A M Sanders; Bart J Vlaminckx; Hester E de Melker; Arie van der Ende; Mirjam J Knol
Journal:  Euro Surveill       Date:  2017-03-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.